Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo
Abstract Several studies indicate that erythropoietin (EPO) has remarkable neuroprotective effects in various central nervous system disorders, while little is known about the effects of EPO in diabetes-associated cognitive dysfunction. Therefore, the present study aimed to investigate whether EPO a...
Guardado en:
Autores principales: | Meng Wang, Wenhui Yan, Yuan Liu, Hao Hu, Qiang Sun, Xinlin Chen, Weijin Zang, Lina Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5b10f1360684aad8b1da859e2ea4d52 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological Inhibition of Galectin-3 Ameliorates Diabetes-Associated Cognitive Impairment, Oxidative Stress and Neuroinflammation in vivo and in vitro
por: Yin Q, et al.
Publicado: (2020) -
Erythropoietin promotes hippocampal mitochondrial function and enhances cognition in mice
por: Robert A. Jacobs, et al.
Publicado: (2021) -
Characteristics of erythropoietin antibodies in patients treated with recombinant human erythropoietin
por: A. M. Kudryashova, et al.
Publicado: (2020) -
Association Between Inflammatory Biomarkers and Cognitive Dysfunction Analyzed by MRI in Diabetes Patients
por: Yang X, et al.
Publicado: (2020) -
The use of erythropoietins in oncology
por: Liliya E. Ziganshina, et al.
Publicado: (2021)